Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm.
This report aims to provide a comprehensive presentation of the global market for Female Sexual Dysfunction Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Female Sexual Dysfunction Treatment. This report contains market size and forecasts of Female Sexual Dysfunction Treatment in global, including the following market information:
- Global Female Sexual Dysfunction Treatment Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The global Female Sexual Dysfunction Treatment market was valued at US$ 126.1 million in 2022 and is projected to reach US$ 762.6 million by 2029, at a CAGR of 29.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The increasing prevalence of chronic diseases is one of the key factors that will drive the growth of the market during the forecast period. Women suffering from chronic health conditions such as diabetes may also be diagnosed with sexual dysfunction. Clinical indications, including hypertension, obesity, metabolic syndrome, and atherogenic dyslipidemia, of chronic conditions such as diabetes, are the risk factors for sexual dysfunctions in women. The rising prevalence of chronic health conditions in women will increase the incidence of female sexual dysfunctions. This will provide considerable growth opportunities to market participants.
Mental health conditions such as depression are being recognized as critical health issues mostly among women. As a result, many pharmaceutical companies are releasing drugs and therapies to treat these conditions leading to an increase in the consumption of antidepressants, antipsychotics, and antiepileptics. Moreover, there is also an increase in the consumption of contraceptives. These drugs cause sexual dysfunctions in women.
We surveyed the Female Sexual Dysfunction Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Female Sexual Dysfunction Treatment Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Female Sexual Dysfunction Treatment Market Segment Percentages, by Type, 2022 (%)
- Non-hormonal Therapy
- Hormonal Therapy
Global Female Sexual Dysfunction Treatment Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Female Sexual Dysfunction Treatment Market Segment Percentages, by Application, 2022 (%)
- Sexual Desire Disorders
- Sexual Arousal Disorders
- Orgasm Disorders
- Sexual Pain Disorders
- Post-orgasmic Diseases
- Pelvic Floor Dysfunction
- Other
Global Female Sexual Dysfunction Treatment Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Female Sexual Dysfunction Treatment Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Female Sexual Dysfunction Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Female Sexual Dysfunction Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AMAG Pharmaceuticals Inc.
- Duchesnay Inc.
- Emotional Brain BV
- Novo Nordisk AS
- Sprout Pharmaceuticals Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Female Sexual Dysfunction Treatment, market overview.
Chapter 2: Global Female Sexual Dysfunction Treatment market size in revenue.
Chapter 3: Detailed analysis of Female Sexual Dysfunction Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Female Sexual Dysfunction Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Female Sexual Dysfunction Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Female Sexual Dysfunction Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Female Sexual Dysfunction Treatment Overall Market Size
2.1 Global Female Sexual Dysfunction Treatment Market Size: 2022 VS 2030
2.2 Global Female Sexual Dysfunction Treatment Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Female Sexual Dysfunction Treatment Players in Global Market
3.2 Top Global Female Sexual Dysfunction Treatment Companies Ranked by Revenue
3.3 Global Female Sexual Dysfunction Treatment Revenue by Companies
3.4 Top 3 and Top 5 Female Sexual Dysfunction Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Female Sexual Dysfunction Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Female Sexual Dysfunction Treatment Players in Global Market
3.6.1 List of Global Tier 1 Female Sexual Dysfunction Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Female Sexual Dysfunction Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Female Sexual Dysfunction Treatment Market Size Markets, 2022 & 2030
4.1.2 Non-hormonal Therapy
4.1.3 Hormonal Therapy
4.2 By Type - Global Female Sexual Dysfunction Treatment Revenue & Forecasts
4.2.1 By Type - Global Female Sexual Dysfunction Treatment Revenue, 2018-2023
4.2.2 By Type - Global Female Sexual Dysfunction Treatment Revenue, 2024-2030
4.2.3 By Type - Global Female Sexual Dysfunction Treatment Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Female Sexual Dysfunction Treatment Market Size, 2022 & 2030
5.1.2 Sexual Desire Disorders
5.1.3 Sexual Arousal Disorders
5.1.4 Orgasm Disorders
5.1.5 Sexual Pain Disorders
5.1.6 Post-orgasmic Diseases
5.1.7 Pelvic Floor Dysfunction
5.1.8 Other
5.2 By Application - Global Female Sexual Dysfunction Treatment Revenue & Forecasts
5.2.1 By Application - Global Female Sexual Dysfunction Treatment Revenue, 2018-2023
5.2.2 By Application - Global Female Sexual Dysfunction Treatment Revenue, 2024-2030
5.2.3 By Application - Global Female Sexual Dysfunction Treatment Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Female Sexual Dysfunction Treatment Market Size, 2022 & 2030
6.2 By Region - Global Female Sexual Dysfunction Treatment Revenue & Forecasts
6.2.1 By Region - Global Female Sexual Dysfunction Treatment Revenue, 2018-2023
6.2.2 By Region - Global Female Sexual Dysfunction Treatment Revenue, 2024-2030
6.2.3 By Region - Global Female Sexual Dysfunction Treatment Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Female Sexual Dysfunction Treatment Revenue, 2018-2030
6.3.2 US Female Sexual Dysfunction Treatment Market Size, 2018-2030
6.3.3 Canada Female Sexual Dysfunction Treatment Market Size, 2018-2030
6.3.4 Mexico Female Sexual Dysfunction Treatment Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Female Sexual Dysfunction Treatment Revenue, 2018-2030
6.4.2 Germany Female Sexual Dysfunction Treatment Market Size, 2018-2030
6.4.3 France Female Sexual Dysfunction Treatment Market Size, 2018-2030
6.4.4 U.K. Female Sexual Dysfunction Treatment Market Size, 2018-2030
6.4.5 Italy Female Sexual Dysfunction Treatment Market Size, 2018-2030
6.4.6 Russia Female Sexual Dysfunction Treatment Market Size, 2018-2030
6.4.7 Nordic Countries Female Sexual Dysfunction Treatment Market Size, 2018-2030
6.4.8 Benelux Female Sexual Dysfunction Treatment Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Female Sexual Dysfunction Treatment Revenue, 2018-2030
6.5.2 China Female Sexual Dysfunction Treatment Market Size, 2018-2030
6.5.3 Japan Female Sexual Dysfunction Treatment Market Size, 2018-2030
6.5.4 South Korea Female Sexual Dysfunction Treatment Market Size, 2018-2030
6.5.5 Southeast Asia Female Sexual Dysfunction Treatment Market Size, 2018-2030
6.5.6 India Female Sexual Dysfunction Treatment Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Female Sexual Dysfunction Treatment Revenue, 2018-2030
6.6.2 Brazil Female Sexual Dysfunction Treatment Market Size, 2018-2030
6.6.3 Argentina Female Sexual Dysfunction Treatment Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Female Sexual Dysfunction Treatment Revenue, 2018-2030
6.7.2 Turkey Female Sexual Dysfunction Treatment Market Size, 2018-2030
6.7.3 Israel Female Sexual Dysfunction Treatment Market Size, 2018-2030
6.7.4 Saudi Arabia Female Sexual Dysfunction Treatment Market Size, 2018-2030
6.7.5 UAE Female Sexual Dysfunction Treatment Market Size, 2018-2030
7 Female Sexual Dysfunction Treatment Companies Profiles
7.1 AMAG Pharmaceuticals Inc.
7.1.1 AMAG Pharmaceuticals Inc. Company Summary
7.1.2 AMAG Pharmaceuticals Inc. Business Overview
7.1.3 AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Major Product Offerings
7.1.4 AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue in Global Market (2018-2023)
7.1.5 AMAG Pharmaceuticals Inc. Key News & Latest Developments
7.2 Duchesnay Inc.
7.2.1 Duchesnay Inc. Company Summary
7.2.2 Duchesnay Inc. Business Overview
7.2.3 Duchesnay Inc. Female Sexual Dysfunction Treatment Major Product Offerings
7.2.4 Duchesnay Inc. Female Sexual Dysfunction Treatment Revenue in Global Market (2018-2023)
7.2.5 Duchesnay Inc. Key News & Latest Developments
7.3 Emotional Brain BV
7.3.1 Emotional Brain BV Company Summary
7.3.2 Emotional Brain BV Business Overview
7.3.3 Emotional Brain BV Female Sexual Dysfunction Treatment Major Product Offerings
7.3.4 Emotional Brain BV Female Sexual Dysfunction Treatment Revenue in Global Market (2018-2023)
7.3.5 Emotional Brain BV Key News & Latest Developments
7.4 Novo Nordisk AS
7.4.1 Novo Nordisk AS Company Summary
7.4.2 Novo Nordisk AS Business Overview
7.4.3 Novo Nordisk AS Female Sexual Dysfunction Treatment Major Product Offerings
7.4.4 Novo Nordisk AS Female Sexual Dysfunction Treatment Revenue in Global Market (2018-2023)
7.4.5 Novo Nordisk AS Key News & Latest Developments
7.5 Sprout Pharmaceuticals Inc.
7.5.1 Sprout Pharmaceuticals Inc. Company Summary
7.5.2 Sprout Pharmaceuticals Inc. Business Overview
7.5.3 Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Major Product Offerings
7.5.4 Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue in Global Market (2018-2023)
7.5.5 Sprout Pharmaceuticals Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Female Sexual Dysfunction Treatment Market Opportunities & Trends in Global Market
Table 2. Female Sexual Dysfunction Treatment Market Drivers in Global Market
Table 3. Female Sexual Dysfunction Treatment Market Restraints in Global Market
Table 4. Key Players of Female Sexual Dysfunction Treatment in Global Market
Table 5. Top Female Sexual Dysfunction Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Female Sexual Dysfunction Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Female Sexual Dysfunction Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Female Sexual Dysfunction Treatment Product Type
Table 9. List of Global Tier 1 Female Sexual Dysfunction Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Female Sexual Dysfunction Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Female Sexual Dysfunction Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Female Sexual Dysfunction Treatment Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Female Sexual Dysfunction Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Female Sexual Dysfunction Treatment Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Female Sexual Dysfunction Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Female Sexual Dysfunction Treatment Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2024-2030
Table 30. AMAG Pharmaceuticals Inc. Company Summary
Table 31. AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Offerings
Table 32. AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. AMAG Pharmaceuticals Inc. Key News & Latest Developments
Table 34. Duchesnay Inc. Company Summary
Table 35. Duchesnay Inc. Female Sexual Dysfunction Treatment Product Offerings
Table 36. Duchesnay Inc. Female Sexual Dysfunction Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Duchesnay Inc. Key News & Latest Developments
Table 38. Emotional Brain BV Company Summary
Table 39. Emotional Brain BV Female Sexual Dysfunction Treatment Product Offerings
Table 40. Emotional Brain BV Female Sexual Dysfunction Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Emotional Brain BV Key News & Latest Developments
Table 42. Novo Nordisk AS Company Summary
Table 43. Novo Nordisk AS Female Sexual Dysfunction Treatment Product Offerings
Table 44. Novo Nordisk AS Female Sexual Dysfunction Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Novo Nordisk AS Key News & Latest Developments
Table 46. Sprout Pharmaceuticals Inc. Company Summary
Table 47. Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Offerings
Table 48. Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Sprout Pharmaceuticals Inc. Key News & Latest Developments
List of Figures
Figure 1. Female Sexual Dysfunction Treatment Segment by Type in 2022
Figure 2. Female Sexual Dysfunction Treatment Segment by Application in 2022
Figure 3. Global Female Sexual Dysfunction Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Female Sexual Dysfunction Treatment Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Female Sexual Dysfunction Treatment Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Female Sexual Dysfunction Treatment Revenue in 2022
Figure 8. By Type - Global Female Sexual Dysfunction Treatment Revenue Market Share, 2018-2030
Figure 9. By Application - Global Female Sexual Dysfunction Treatment Revenue Market Share, 2018-2030
Figure 10. By Type - Global Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Female Sexual Dysfunction Treatment Revenue Market Share, 2018-2030
Figure 12. By Application - Global Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Female Sexual Dysfunction Treatment Revenue Market Share, 2018-2030
Figure 14. By Region - Global Female Sexual Dysfunction Treatment Revenue Market Share, 2018-2030
Figure 15. By Country - North America Female Sexual Dysfunction Treatment Revenue Market Share, 2018-2030
Figure 16. US Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Female Sexual Dysfunction Treatment Revenue Market Share, 2018-2030
Figure 20. Germany Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2030
Figure 21. France Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Female Sexual Dysfunction Treatment Revenue Market Share, 2018-2030
Figure 28. China Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2030
Figure 32. India Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Female Sexual Dysfunction Treatment Revenue Market Share, 2018-2030
Figure 34. Brazil Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Female Sexual Dysfunction Treatment Revenue Market Share, 2018-2030
Figure 37. Turkey Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Female Sexual Dysfunction Treatment Revenue, (US$, Mn), 2018-2030
Figure 41. AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Duchesnay Inc. Female Sexual Dysfunction Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Emotional Brain BV Female Sexual Dysfunction Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novo Nordisk AS Female Sexual Dysfunction Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
